IRICK JAIME A purchased $230K of TRNS
IRICK JAIME A (President and CEO) purchased 2,275 shares of TRANSCAT INC (TRNS) at $101.26 ($0.23M total) on 2026-11-05.
TRANSCAT INC
Transcat provides calibration, repair, inspection, maintenance, validation, quality and compliance, and related services to customers in regulated industries, particularly life sciences, as well as aerospace and defense, energy and utilities, and industrial sectors. It operates through Service and Distribution segments. Service offerings include recurring instrument calibrations, onsite and mobile services, client-based labs, consulting, and asset management solutions supported by its CalTrak software and C3 customer portal. Distribution sells and rents new and used test, measurement, and control instruments from national and proprietary brands, with options including pre-shipment calibration, equipment kitting, and technical support. Transcat serves approximately 27,000 customers. It makes money by providing services and by selling and renting instruments, primarily through its website and sales teams. As of the end of fiscal 2026, it operates 33 calibration service centers across the United States, including Puerto Rico, Canada, and Ireland. Transcat is headquartered in Rochester, New York.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
IRICK JAIME A (President and CEO) purchased 2,275 shares of TRANSCAT INC (TRNS) at $101.26 ($0.23M total) on 2026-11-05.
Analysts made several calls: Morgan Stanley reiterated SpaceX as overweight, Citi upgraded Coupang to buy, Guggenheim initiated Lockheed Martin as buy, Rosenblatt upgraded Navitas Semiconductor to buy, Barclays reiterated AMD as overweight, Wolfe upgraded MSG Knickerbockers and initiated MSG Rangers as outperform, Truist upgraded Edwards Lifesciences to buy, Evercore ISI reiterated Apple as outperform, Citi downgraded Adobe to sell, Morgan Stanley downgraded Flagstar to underweight, Wells Fargo…
Oppenheimer upgraded Transcat (TRNS) to Outperform with a $115 target, citing strong Q2 FY2027 results. The company reported $0.64 EPS (vs. $0.42 est.), $97.1M revenue (vs. $89.97M est.), and 23% EBITDA growth. Oppenheimer raised EBITDA estimates for FY2027 and FY2028 by 5% and 8%, respectively, expecting 9% organic service growth.
Over the past 7 days, AlphAI's AI scored 8 news stories mentioning TRNS (TRANSCAT INC). Coverage has skewed bullish: 8 bullish, 0 neutral, and 0 bearish.
Recent TRNS coverage spans earnings, financial news and insider activity.
In the last 30 days, TRNS insiders filed 1 SEC Form 4 transaction — 1 purchase ($230K) and no sales. The most active reporter was IRICK JAIME A, President and CEO, with 1 filing.
Small insider purchase may signal confidence but size is modest relative to market cap.
Positive outlook on margins may boost stock.
The upgrade and strong earnings suggest upside potential.
Guidance lift and strong earnings suggest upside potential.
Positive earnings surprise may generate modest buying pressure.
AlphAI scores every news story that mentions TRNS with an AI model for sentiment and relevance, and aggregates insider trades from TRANSCAT INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
IRICK JAIME A (President and CEO) purchased 2,275 shares of TRANSCAT INC (TRNS) at $101.26 ($0.23M total) on 2026-11-05.
Analysts made several calls: Morgan Stanley reiterated SpaceX as overweight, Citi upgraded Coupang to buy, Guggenheim initiated Lockheed Martin as buy, Rosenblatt upgraded Navitas Semiconductor to buy, Barclays reiterated AMD as overweight, Wolfe upgraded MSG Knickerbockers and initiated MSG Rangers as outperform, Truist upgraded Edwards Lifesciences to buy, Evercore ISI reiterated Apple as outperform, Citi downgraded Adobe to sell, Morgan Stanley downgraded Flagstar to underweight, Wells Fargo…
Oppenheimer upgraded Transcat (TRNS) to Outperform with a $115 target, citing strong Q2 FY2027 results. The company reported $0.64 EPS (vs. $0.42 est.), $97.1M revenue (vs. $89.97M est.), and 23% EBITDA growth. Oppenheimer raised EBITDA estimates for FY2027 and FY2028 by 5% and 8%, respectively, expecting 9% organic service growth.
Transcat (TRNS) reported Q2 growth in distribution revenue (10% to $32.3M) and adjusted EBITDA (23% to $14.9M). Management raised its fiscal 2027 service organic revenue growth outlook to low-double-digits and expects service gross-margin expansion. The company highlighted demand in regulated markets and completed an acquisition to expand its biomedical calibration footprint.
Transcat (TRNS) reported Q3 2026 revenue of $97.09M, up 18% YoY and 5% above estimates. Adjusted EPS of $0.64 beat estimates by 42.9%. Operating margin was 5.2%, stable YoY. CEO highlighted strong service revenue growth and strategic acquisitions. Analysts expect 5% revenue growth over the next 12 months.
TRANSCAT INC (TRNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE Transcat, Inc. 35 Vantage Point Drive • Rochester • NY • 14624 • Phone: (585) 352-7777 Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin Expansion •
Northland upgraded Transcat (TRNS) to Outperform with a $95 price target, citing valuation and technical support. TRNS trades at $81.71 with a P/E of 227.43, showing 20.91% revenue growth. Q2 fiscal 2027 results are due Nov 17. Q1 results beat expectations with $0.51 EPS and $92.9M revenue, up 22% YoY.
Fastenal (FAST) reported Q2 revenue of $2.46B, up 15.5% YoY, beating estimates. DXP (DXPE) reported $576.5M, up 15.6%, also beating estimates. Transcat (TRNS) reported $92.95M, up 21.6%, with the largest estimate beat. FAST is up 1.3%, DXPE up 5.9%, TRNS down 10.3% since earnings.
Global Industrial (NYSE:GIC) reported $386.6M revenue, up 7.7% YoY, beating estimates. Transcat (NASDAQ:TRNS) saw $92.95M revenue, up 21.6%, exceeding expectations. W.W. Grainger (NYSE:GWW) reported $5.02B revenue, up 10.3%, topping forecasts. Stocks reacted differently post-results.
TRANSCAT INC (TRNS) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. At the annual meeting of shareholders of the Company held on September 9, 2026, the Company's shareholders voted on the matters described below: Proposal 1 : The Company's shareholders elected the following nominees a